"Donors are heroes" is a transplant axiom. Unfortunately, many history elements that go into labeling a donor public health servicehigh risk (PHS-HR), ie, increased risk for transmitting HIV, hepatitis C (HCV), and hepatitis B (HBV), chip away at this dictum because of associated stigma. We read the article by There are now substantial data on PHS-HR organs. HIV is of greatest concern to candidates, but its risk is best described as miniscule, with transmission risk for nucleic acid test (NAT) negative donors being ≤ 0.12% across all PHS-HR categories. 4 With no documented transmission since 2013, despite an increased use of PHS-HR organs, ≤ 0.12% is likely an inflated estimate. HCV risk has variability between donor history elements with the donor discovered with needle in arm proceeding rapidly to donation thought to have a 3% risk of NAT negative transmission. 2 The intravenous drug use category confers a 0.32% risk of transmission, whereas for all remaining categories, it is ≤ 0.12%. 5 HBV is of less concern because dialysis units utilize vaccination programs to achieve seroconversion.Although screening methodology is not foolproof because of reliance on surrogates to obtain donor history and the rare potential for lab error, but this is factored into historical data.